TIPE2 and cervical squamous cell carcinoma: The DFI results demonstrated that TNFAIP8L2 expression is a risk for patients with HNSC and the PFI data showed that TNFAIP8L2 was a risk for patients with KICH, KIRCA and LGG but had a protective function for patients with CESC.